American Skin Association Honors Sun Pharma at Annual Gala with Leadership Award
On a remarkable evening at The Plaza Hotel, the American Skin Association (ASA) hosted its Annual Gala, celebrating the vital contributions made towards skin health and innovation. With more than 300 devoted supporters present, including prominent business leaders, philanthropists, and respected dermatologists, the gala was a testament to the community's combined efforts in advancing skin health initiatives.
NBC’s Emmy-winning weather anchor, Dave Price, took center stage as the Master of Ceremonies, guiding the evening's festivities. As the night unfolded, the spotlight shone brightly on Sun Pharma, a global leader in pharmaceutical innovation recognized for its significant contributions to the dermatology field. The company was the proud recipient of the ASA's prestigious Corporate Leadership Award for 2026, which was presented by Dr. Emma Guttman-Yassky, MD, PhD. Sridhar Shankar and John Bujnoski from Sun Pharma accepted the award on behalf of the firm, marking a proud moment in the collaboration between corporate ingenuity and healthcare advancement.
Howard P. Milstein, the Chairman of ASA, expressed his sentiments about the award, noting, “ASA is proud to present Sun Pharma with this well-deserved award for their enduring dedication to dermatology. Their pursuit of research and education aligns with our objectives, and we look forward to continuing our partnership in the search for breakthroughs to combat skin diseases.”
Established in 1983, Sun Pharma has emerged as a dominant player in the market, particularly in the realm of dermatological medicines in the U.S. The company's scope of work not only encompasses innovative treatments but extends into specialized areas such as cutaneous oncology and dermatological immunology.
Throughout its extensive history, Sun Pharma has pioneered advancements in the care of patients suffering from skin ailments, especially those afflicted by skin cancer. Their strategic collaborations within the dermatological community underscore their commitment to addressing unmet medical needs across a continuum of skin diseases. As expressed by Rick Ascroft, CEO of Sun Pharma, “Receiving recognition from the American Skin Association is a tremendous honor for us. Our focus on innovation stems from a deep-rooted responsibility to improve patient care. Through scientific advancement, collaborative efforts, and increasing accessibility to treatment options, we aspire to leave a lasting impact in dermatology.”
Notably, in conjunction with its financial support, Sun Pharma has fueled significant initiatives such as the launch of the SkinSight Podcast series in 2026, aimed at educating patients about common skin conditions. This podcast, made available on platforms like Apple Podcasts and Spotify, conveys helpful information through discussions on real-life patient experiences and insights from dermatological experts.
Dr. James G. Krueger, President of ASA, emphasized, “We are thrilled to expand our partnership with Sun Pharma, providing vital resources and hope to patients and their families.” The association has, over the years, awarded over $50 million in research grants to more than 350 emerging scientists dedicated to developing innovative solutions for skin cancer and diseases. This support is not only instrumental in funding groundbreaking research but also drives forward critical studies addressing conditions like melanoma, psoriasis, atopic dermatitis, and more.
The ASA has also championed educational outreach through programs like SPOTS (Sun Protection Outreach Teaching by Students), equipping students from early childhood to high school with essential knowledge about skin health and the importance of early detection in preventing skin cancer. The organization remains focused on promoting awareness of skin health and is committed to advancing critical research in the field.
As ASA continues to lead the charge in improving skin health and understanding in society, the partnership with Sun Pharma exemplifies how collaborative efforts can pave the way for innovative solutions, educational outreach, and ultimately, a more informed community regarding skin diseases. With a clear vision moving forward, ASA is guided by its mission to enhance skin health awareness and support vital scientific advancements, fostering a community with greater skin health understanding and education.
NBC’s Emmy-winning weather anchor, Dave Price, took center stage as the Master of Ceremonies, guiding the evening's festivities. As the night unfolded, the spotlight shone brightly on Sun Pharma, a global leader in pharmaceutical innovation recognized for its significant contributions to the dermatology field. The company was the proud recipient of the ASA's prestigious Corporate Leadership Award for 2026, which was presented by Dr. Emma Guttman-Yassky, MD, PhD. Sridhar Shankar and John Bujnoski from Sun Pharma accepted the award on behalf of the firm, marking a proud moment in the collaboration between corporate ingenuity and healthcare advancement.
Howard P. Milstein, the Chairman of ASA, expressed his sentiments about the award, noting, “ASA is proud to present Sun Pharma with this well-deserved award for their enduring dedication to dermatology. Their pursuit of research and education aligns with our objectives, and we look forward to continuing our partnership in the search for breakthroughs to combat skin diseases.”
Established in 1983, Sun Pharma has emerged as a dominant player in the market, particularly in the realm of dermatological medicines in the U.S. The company's scope of work not only encompasses innovative treatments but extends into specialized areas such as cutaneous oncology and dermatological immunology.
Throughout its extensive history, Sun Pharma has pioneered advancements in the care of patients suffering from skin ailments, especially those afflicted by skin cancer. Their strategic collaborations within the dermatological community underscore their commitment to addressing unmet medical needs across a continuum of skin diseases. As expressed by Rick Ascroft, CEO of Sun Pharma, “Receiving recognition from the American Skin Association is a tremendous honor for us. Our focus on innovation stems from a deep-rooted responsibility to improve patient care. Through scientific advancement, collaborative efforts, and increasing accessibility to treatment options, we aspire to leave a lasting impact in dermatology.”
Notably, in conjunction with its financial support, Sun Pharma has fueled significant initiatives such as the launch of the SkinSight Podcast series in 2026, aimed at educating patients about common skin conditions. This podcast, made available on platforms like Apple Podcasts and Spotify, conveys helpful information through discussions on real-life patient experiences and insights from dermatological experts.
Dr. James G. Krueger, President of ASA, emphasized, “We are thrilled to expand our partnership with Sun Pharma, providing vital resources and hope to patients and their families.” The association has, over the years, awarded over $50 million in research grants to more than 350 emerging scientists dedicated to developing innovative solutions for skin cancer and diseases. This support is not only instrumental in funding groundbreaking research but also drives forward critical studies addressing conditions like melanoma, psoriasis, atopic dermatitis, and more.
The ASA has also championed educational outreach through programs like SPOTS (Sun Protection Outreach Teaching by Students), equipping students from early childhood to high school with essential knowledge about skin health and the importance of early detection in preventing skin cancer. The organization remains focused on promoting awareness of skin health and is committed to advancing critical research in the field.
As ASA continues to lead the charge in improving skin health and understanding in society, the partnership with Sun Pharma exemplifies how collaborative efforts can pave the way for innovative solutions, educational outreach, and ultimately, a more informed community regarding skin diseases. With a clear vision moving forward, ASA is guided by its mission to enhance skin health awareness and support vital scientific advancements, fostering a community with greater skin health understanding and education.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.